PTC Therapeutics | PTCT - Ebit



PTC Therapeutics reported $-34858000 in EBIT for its fiscal quarter ending in June of 2025.


Ebit Change Date
Acadia Pharmaceuticals USD 32.37M 13.08M Jun/2025
Alnylam Pharmaceuticals USD 4.89M 13.19M Jun/2025
Amgen USD 2.26B 1.34B Jun/2025
Biogen USD 816.6M 233.8M Jun/2025
BioMarin Pharmaceutical USD 276.89M 52.99M Jun/2025
Cytokinetics USD -111506000 44.12M Jun/2025
Daiichi Sankyo JPY 96.71B 69.64B Jun/2025
Gilead Sciences USD 2.7B 189M Jun/2025
Incyte USD 310.82M 27.18M Jun/2025
Ionis Pharmaceuticals USD 144.78M 290.78M Jun/2025
Ironwood Pharmaceuticals USD 33.22M 7.58M Dec/2024
Novartis USD -9190000000 13.87B Jun/2025
Pfizer USD 2.6B 3.33B Jun/2025
PTC Therapeutics USD -34858000 1.01B Jun/2025
Roche Holding CHF 11.29B 2.68B Jun/2024
Sarepta Therapeutics USD 115.58M 415.96M Jun/2025
TG Therapeutics USD 34.84M 22.62M Jun/2025
Ultragenyx Pharmaceutical USD -193567000 50.63M Jun/2025
Vertex Pharmaceuticals USD 1.15B 420.8M Jun/2025
Xencor USD -22832000 16.77M Jun/2025